Peer-reviewed journal articles:

Malmqvist, T., Spickett, C., Gallo, J.-M. and Anthony, K. (2017). A UV cross-linking method combined with infrared imaging to analyse RNA-protein interactions. Biology Methods & Protocols. (In press)

Anthony, K., Arechavala-Gomeza, V., Taylor, L. E., Vulin, A., Kaminoh, Y., Torelli, S., . . . Muntoni, F. (2014). Dystrophin quantification: Biological and translational research implications. Neurology, 83 (22), 2062-2069. Link

Malmqvist, T., Anthony, K., & Gallo, J. -. M. (2014). Tau mRNA is present in axonal RNA granules and is associated with elongation factor 1A. Brain Research, 1584, 22-27. Link

Anthony, K., Arechavala-Gomeza, V., Ricotti, V., Torelli, S., Feng, L., Janghra, N., . . . Muntoni, F. (2014). Biochemical characterization of patients with in-frame or out-of-frame DMD deletions pertinent to exon 44 or 45 skipping. JAMA Neurol, 71 (1), 32-40. Link

Zhou, H., Janghra, N., Mitrpant, C., Dickinson, R. L., Anthony, K., Price, L., . . . Muntoni, F. (2013). A novel morpholino oligomer targeting ISS-N1 improves rescue of severe spinal muscular atrophy transgenic mice. Hum Gene Ther, 24 (3), 331-342. Link

Anthony, K., Feng, L., Arechavala-Gomeza, V., Guglieri, M., Straub, V., Bushby, K., . . . Muntoni, F. (2012). Exon skipping quantification by quantitative reverse-transcription polymerase chain reaction in Duchenne muscular dystrophy patients treated with the antisense oligomer eteplirsen. Hum Gene Ther Methods, 23 (5), 336-345. Link

Arechavala-Gomeza, V., Anthony, K., Morgan, J., & Muntoni, F. (2012). Antisense oligonucleotide-mediated exon skipping for Duchenne muscular dystrophy: progress and challenges. Curr Gene Ther, 12 (3), 152-160. Link

Cirak, S., Feng, L., Anthony, K., Arechavala-Gomeza, V., Torelli, S., Sewry, C., . . . Muntoni, F. (2012). Restoration of the dystrophin-associated glycoprotein complex after exon skipping therapy in Duchenne muscular dystrophy. Mol Ther, 20 (2), 462467. Link

Anthony, K., Cirak, S., Torelli, S., Tasca, G., Feng, L., Arechavala-Gomeza, V., . . . Muntoni, F. (2011). Dystrophin quantification and clinical correlations in Becker muscular dystrophy: implications for clinical trials. Brain, 134 (Pt 12), 3547-3559. Link

Cirak, S., Arechavala-Gomeza, V., Guglieri, M., Feng, L., Torelli, S., Anthony, K., . . . Muntoni, F. (2011). Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study. Lancet, 378 (9791), 595-605. Link

Anthony K and Gallo J.M, (2010). Aberrant RNA processing events in neurological disorders. Brain Res. 1338, 67-77. Link

Rodriguez-Martin T., Anthony K., Garcia-Blanco M.A., Mansfield S.G., Anderton B.H. and Gallo J.M. (2009). Correction of tau missplicing caused by FTDP-17 MAPT mutations by spliceosome-mediated RNA trans-splicing. Hum. Mol. Genet. 18, 3266-3273. Link

Chapple J.P*., Anthony K*., Martin T.R., Dev A., Cooper T.A and Gallo J.M. (2007). Expression, localization and tau exon 10 splicing activity of the brain RNA-binding protein TNRC4. Hum. Mol. Genet. 16, 2760-2769. Link

Selected abstracts and meeting presentations:

Ricotti, V., Eagle, M., Butler, J., Decostre, V., Deborah, R., Moraux, A., Anthony, K., Sleby, V., Guglieri, M., Van der Holst, M., Jansen, M., Morgan, J., de Groot, I.,Niks, E., Verschuuren, J., Servais, L., Hogrel, J. Y., Voit, T., Straub, V. and Muntoni, F. (2015) G.P.147 – Outcome measures for Duchenne muscular dystrophy from ambulant to non-ambulant: implications for clinical trials. Neuromuscular Disorders, 25(Supp 2), S229. 0960-8966.  20th International Congress of the World Muscle Society, Brighton, UK  Link

Zaharieva, I., Cirak, S., Anthony, K., Feng, L., Tasca, G., Ferlini, A., Morgan, J.and Muntoni, F. (2015) G.P.228 – Micro RNA profile associated with the dystrophin level in Becker muscular dystrophy. Neuromuscular Disorders, 25(Supp 2), S255. 0960-8966.  20th International Congress of the World Muscle Society, Brighton, UK Link

Anthony, K., Ricotti, V., Guglieri, M., Servais, L., Voit, T., Bushby, K., . . . Muntoni, F. (2013). Assessing T cell-mediated immune response to dystrophin in the natural history of Duchenne muscular dystrophy. Neuromuscular Disorders, 23 (9-10), 843. 18th International Congress of the World Muscle Society, Asilomar, California, USA Link

Anthony, K., Arechavala-Gomeza, V., Ricotti, V., Torelli, S., Feng, L., Tasca, G., . . . Muntoni, F. (2012). Biochemical and clinical variability of Becker muscular dystrophy: Predicting optimal target exons for exon skipping therapy in Duchenne muscular dystrophy. Neuromuscular Disorders, 22 (9-10), 862. 17th International Congress of the World Muscle Society, Perth, Australia Link

Anthony, K., Feng L., Arechavala-Gomeza V., Morgan J., Muntoni F. (2011). A TaqMan qRT-PCR assay to assess patient response in exon skipping clinical trials for Duchenne muscular dystrophy. TREAT-NMD Global Conference, Geneva, Switzerland

Anthony, K., Chapple J.P and Gallo J.M. (2007). Identification of regulators of tau mRNA localisation. 37th annual meeting of the Society for Neuroscience, San Diego, California, USA